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Fig 1. Subcorneal pustular dermatosis. A, Pustular
eruption on the trunk, the proximal limbs, and in the
large folds. B, Hypopyon-like accumulation of pus.
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Subcorneal pustular dermatosis associated
with Mycoplasma pneumoniae infection
To the Editor: Subcorneal pustular dermatosis (SPD)
or Sneddon-Wilkinson disease is a rare, chronic, and
relapsing skin disorder, consisting of a symmetric
sterile pustular eruption that primarily involves trunk
and large skin folds. Flaccid, subcorneal pustules
are half-filled with pus with a hypopyon-like
appearance, containing polymorphonuclear neutro-
phils. The pathophysiology is unknown, but
common associations include monoclonal IgA
paraproteins, inflammatory bowel disease, and
rheumatoid arthritis. We describe a rare association
of SPD with Mycoplasma pneumoniae infection.
A 36-year-old woman, without significant per-
sonal or familial medical history (including psoria-
sis), presented with a rash for the last 5 days. She
reported a dry cough without fever, night sweats, or
other symptoms for the last week. Cutaneous exam-
ination revealed a pustular eruption on the trunk,
proximal limbs, and large folds (Fig 1, A), consisting
of large pustules with hypopyon-like accumulation
of pus (Fig 1, B). Face, scalp, palms, soles, nails,
and mucous membranes were spared. The rest
of physical examination revealed unremarkable
findings. No drug had been introduced before
the eruption. Histologic examination showed a
subcorneal unilocular pustule without spongiosis
containing polymorphonuclear neutrophils with
rare acantholytic keratinocytes. Direct immunofluo-
rescence did not show immunoglobulin or comple-
ment deposition. Bacteriologic, virologic, and
mycologic cultures of pus produced negative results,
as did indirect immunofluorescence. Laboratory tests
found mildly elevated C-reactive protein. These
findings were consistent with the diagnosis of SPD.Open access under CC BY-NC-ND license.Antinuclear antibodies, serum protein electropho-
resis, plasma immunoglobulin levels, and circulating
lymphocyte flow cytometry produced normal or
negative findings. M pneumoniae IgM and IgG
antibodies were elevated, suggesting recent infec-
tion. Throat swab polymerase chain reaction was
positive forMpneumoniae. Chest x-ray and thoracic-
abdominal-pelvic computed tomography scan
revealed unremarkable results. Oral dapsone was
started but stopped by the patient in a few days
because of nausea. Cutaneous lesions disappeared
in a fewweeks with topical corticosteroids alone. No
recurrence was noted at 18 months’ follow-up.
In spite of rapidly favorable outcome without
recurrence, the clinical and histologic findings were
consistent with SPD. We believe the acute course of
the disease may suggest an infectious origin. In our
case, the patient did not have pneumonia but a mild
upper respiratory tract infection that could have
gone unnoticed. Skin lesions responded to topical
corticosteroids alone, suggesting that systemic
treatment may not be necessary.
Two similar cases of subcorneal pustules after
M pneumoniae respiratory infections have been
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e86 Lettersdescribed, by Papini et al1 in an 8-year-old boy and
by Winnock et al2 in a 43-year-old man. In these 2
cases, dapsone was prescribed without recurrence.
Interestingly, M pneumoniaeeinduced Stevens-
Johnson syndrome with subcorneal pustules has
been described a few times.3-5 However, in our
observation mucous membranes were spared,
rendering Stevens-Johnson less plausible. We sug-
gest that there may be a specific presentation of SPD
of infectious origin, possibly more frequent in young
patients. Our observation highlights the importance
of looking for M pneumoniae in cases of SPD, even
without respiratory symptoms, and suggests topical
treatment for a few weeks may be sufficient if the
eruption is considered secondary to M pneumoniae
infection.
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http://dx.doi.org/10.1016/j.jaad.2014.02.038Rapid deterioration in a patient with primary
aggressive cutaneous epidermotropic CD81
cytotoxic T-cell (‘Berti’) lymphoma after
administration of adalimumab
To the Editor: Primary aggressive cutaneous
epidermotropic CD81 cytotoxic T-cell lymphoma,a World Health Organization provisional entity here
referred to as ‘‘Berti lymphoma,’’ comprises less than
1% of cutaneous T-cell lymphomas (CTCLs).1
Berti lymphoma classically presents as eruptive
hyperkeratotic plaques or nodules with a phase
of ulceration and necrosis.2 The epidermis
exhibits epidermotropism of atypical pleomorphic
lymphocytes and occasional necrotic keratinocytes.2
Dissemination to lung, testis, central nervous system,
and oral mucosa with sparing of lymph nodes is
common.3 We present a case of Berti lymphoma that
arose following a trial of adalimumab in the setting
of a long-standing spongiotic and psoriasiform
dermatitis clinically suggestive of psoriasis.
A 35-year-old African American woman had a
10-year history of nonspecific ‘‘dermatitis.’’ In the
year before her death, she was admitted to her local
hospital several times for shortness of breath
and dermatitis and was repeatedly treated with
prednisone. Skin biopsies from this period showed
a nonspecific spongiotic and psoriasiform dermatitis.
Immunohistochemical analysis failed to demonstrate
any concerning atypical or CD81 epidermotropic
infiltrate. She was seen by a local dermatologist
as an outpatient, psoriasis was diagnosed, and a
single loading dose of adalimumab (80 mg) was
administered. She presented 2 days later to her
local hospital for respiratory decline and rapidly
developing cutaneous ulceration.
On transfer to our institution’s intensive care unit 6
days later, examination revealed skin ulcers localized
primarily to the trunk as well as serpiginous to
arcuate scaly plaques and erosions on the extremities
(Fig 1). A biopsy on an ulcer edge revealed an
epidermotropic infiltrate of atypical CD81 cells
consistent with a diagnosis of Berti lymphoma
(Fig 2). Atypical cells stained diffusely positive by
immunohistochemistry for CD3, CD8, granzyme B,
and TIA-1, with 70% of cells proliferating by Ki-67. A
subpopulation of atypical cells were CD56 positive.
Atypical cells were negative for CD4, CD5, CD7,
CD20, CD30, CD57, CD99, HSV, and TdT. Flow
cytometry of peripheral blood was normal, and
HTLV I/II and EBV were negative. Left upper and
lower lung biopsies revealed focal involvement by
CD81 and CD561 atypical large lymphocytes
consistent with pulmonary lymphoma. Respiratory
function deteriorated, and she died 2 months after
admission.
Adalimumab, a human tumor necrosis factor
(TNF)-alpha monoclonal antibody, is indicated to
treat a range of autoimmune diseases including
psoriasis.4 Whether TNF-alpha blockade is
associated with development of lymphomas is
controversial, but rapid and fatal progression of
